BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24369190)

  • 21. Influence of magnetic resonance imaging in the decision to preserve or resect neurovascular bundles at robotic assisted laparoscopic radical prostatectomy.
    Park BH; Jeon HG; Jeong BC; Seo SI; Lee HM; Choi HY; Jeon SS
    J Urol; 2014 Jul; 192(1):82-8. PubMed ID: 24440235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy.
    Gupta RT; Faridi KF; Singh AA; Passoni NM; Garcia-Reyes K; Madden JF; Polascik TJ
    Urol Oncol; 2014 Nov; 32(8):1292-9. PubMed ID: 24863013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiparametric magnetic resonance imaging for prostate cancer-a comparative study including radical prostatectomy specimens.
    Toner L; Papa N; Perera M; Katelaris N; Weerakoon M; Chin K; Harewood L; Bolton DM; Lawrentschuk N
    World J Urol; 2017 Jun; 35(6):935-941. PubMed ID: 27785560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of pre-biopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer.
    Numao N; Yoshida S; Komai Y; Ishii C; Kagawa M; Kijima T; Yokoyama M; Ishioka J; Matsuoka Y; Koga F; Saito K; Masuda H; Fujii Y; Kawakami S; Kihara K
    J Urol; 2013 Aug; 190(2):502-8. PubMed ID: 23473904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer.
    D'Amico AV; Whittington R; Malkowicz SB; Schultz D; Schnall M; Tomaszewski JE; Wein A
    J Urol; 1995 Jul; 154(1):131-8. PubMed ID: 7539857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study.
    Thompson JE; Moses D; Shnier R; Brenner P; Delprado W; Ponsky L; Pulbrook M; Böhm M; Haynes AM; Hayen A; Stricker PD
    J Urol; 2014 Jul; 192(1):67-74. PubMed ID: 24518762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of Detected and Missed Prostate Cancer Foci on 3-T Multiparametric MRI Using an Endorectal Coil Correlated With Whole-Mount Thin-Section Histopathology.
    Tan N; Margolis DJ; Lu DY; King KG; Huang J; Reiter RE; Raman SS
    AJR Am J Roentgenol; 2015 Jul; 205(1):W87-92. PubMed ID: 26102423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Multiparametric 3T MRI in the routine staging of prostate cancer].
    Largeron JP; Galonnier F; Védrine N; Alfidja A; Boyer L; Pereira B; Boiteux JP; Kemeny JL; Guy L
    Prog Urol; 2014 Mar; 24(3):145-53. PubMed ID: 24560200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?
    Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F
    J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accuracy of Multiparametric Magnetic Resonance Imaging for Extracapsular Extension of Prostate Cancer in Community Practice.
    Davis R; Salmasi A; Koprowski C; Kim S; Kwon YS; Faiena I; Patel N; Elsamra SE; Kim IY
    Clin Genitourin Cancer; 2016 Dec; 14(6):e617-e622. PubMed ID: 27188968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of 3-Tesla multiparametric magnetic resonance imaging and targeted biopsy for improved risk stratification in patients considered for active surveillance.
    Pessoa RR; Viana PC; Mattedi RL; Guglielmetti GB; Cordeiro MD; Coelho RF; Nahas WC; Srougi M
    BJU Int; 2017 Apr; 119(4):535-542. PubMed ID: 27500389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Magnetic resonance imaging in prostate cancer detection and management: a systematic review.
    Monni F; Fontanella P; Grasso A; Wiklund P; Ou YC; Randazzo M; Rocco B; Montanari E; Bianchi G
    Minerva Urol Nefrol; 2017 Dec; 69(6):567-578. PubMed ID: 28488844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience.
    Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM
    Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathologic correlation of transperineal in-bore 3-Tesla magnetic resonance imaging-guided prostate biopsy samples with radical prostatectomy specimen.
    Velez E; Fedorov A; Tuncali K; Olubiyi O; Allard CB; Kibel AS; Tempany CM
    Abdom Radiol (NY); 2017 Aug; 42(8):2154-2159. PubMed ID: 28293720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy.
    Goris Gbenou MC; Peltier A; Addla SK; Lemort M; Bollens R; Larsimont D; Roumeguère T; Schulman CC; van Velthoven R
    Urol Int; 2012; 88(1):12-7. PubMed ID: 22004874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Value of preoperative 3T multiparametric MRI for surgical margin status in patients with prostate cancer.
    Tamada T; Sone T; Kanomata N; Miyaji Y; Kido A; Jo Y; Yamamoto A; Ito K
    J Magn Reson Imaging; 2016 Sep; 44(3):584-93. PubMed ID: 26872679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology.
    Le JD; Tan N; Shkolyar E; Lu DY; Kwan L; Marks LS; Huang J; Margolis DJ; Raman SS; Reiter RE
    Eur Urol; 2015 Mar; 67(3):569-76. PubMed ID: 25257029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen.
    Taneja SS; Penson DF; Epelbaum A; Handler T; Lepor H
    J Urol; 1999 Oct; 162(4):1352-7; discussion 1357-8. PubMed ID: 10492195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative Multiparametric MRI Features and PTEN Expression of Peripheral Zone Prostate Cancer: A Pilot Study.
    McCann SM; Jiang Y; Fan X; Wang J; Antic T; Prior F; VanderWeele D; Oto A
    AJR Am J Roentgenol; 2016 Mar; 206(3):559-65. PubMed ID: 26901012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the current eligibility criteria for focal therapy in men with localized prostate cancer and the role of MRI.
    Pompe RS; Kühn-Thomä B; Nagaraj Y; Veleva V; Preisser F; Leyh-Bannurah SR; Graefen M; Huland H; Tilki D; Salomon G
    World J Urol; 2018 May; 36(5):705-712. PubMed ID: 29492583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.